DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Factor V
Factor V
Activated Protein C Resistance: the Most Common Risk Factor for Venous Thromboembolism
Familial Multiple Coagulation Factor Deficiencies
Regulation of Coagulation by the Fibrinolytic System: Expecting the Unexpected
Alpha-Dystroglycan Plays Functional Roles in Platelet Aggregation and Thrombus Growth
Factor V Leiden Thrombophilia
Factor V Leiden Thrombophilia Jody Lynn Kujovich, MD
Congenital Thrombophilia
Original Article Endogenous Risk Factors for Deep-Vein Thrombosis in Patients with Acute Spinal Cord Injuries
Essential Thrombocythaemia
Factor V Leiden Testing for Thrombophilia
Identification of the Regions in Factor V Mediating Its Edocytosis by Megakaryocytes to Form the Unique Platelet-Derived Cofacto
Genotypes of Patients with Combined Factor V and VIII Deficiency
Neonatal Hematology
Factor V, R2 Variant Indications for Ordering Disease Overview
Bleeding Thrombotic and Platelet Disorder TIER1 Genes (V.ISTH 2019.1)
Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets
Factor V Leiden and Other Coagulation Factor Mutations Affecting Thrombotic Risk
Coagulation Factor Xa (Arachidonic Acid/Factor V Antibody/Thrombin) A
Top View
Factor V Leiden Thrombophilia – F5 Gene
Platelet-Primed Interactions of Coagulation and Anticoagulation Pathways in Flow-Dependent Thrombus Formation
Hypercoagulability Syndromes
Factor V and Antithrombin Gene Mutations in Patients with Idiopathic Central Retinal Vein Occlusion
Factor V Leiden Inherited Prothrombin 20210A Protein C Deficiency Prothrombotic Protein S Deficiency Mutation(S) Antithrombin Deficiency
Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea
Down-Regulation of Platelet Adhesion Receptors Is a Controlling
Resolving Differential Diagnostic Problems in Von Willebrand
Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment
Endocytosis of Plasma-Derived Factor V by Megakaryocytes Occurs Via a Clathrin-Dependent, Specific Membrane Binding Event
Dynamin 2 Is Required for GPVI Signaling and Platelet Hemostatic Function in Mice
©Ferrata Storti Foundation
Factor V Leiden (G16191a)
Factors Contributing to the Hypercoagulable State. Clinical Case of Intracardiac Thrombosis and Massive Pulmonary Embolism
Diagnosis and Treatment of Von Willebrand Disease and Rare Bleeding Disorders
Prevention of Venous Thromboembolism in 2020 and Beyond
Hemostasis and Thrombosis Test Compendium
Factor V Leiden
VTE – Thrombophilia Testing and Treatment Venkatesh Rudrapatna MD Hypercoagulable States - VTE
The Occurrence of Prothrombotic Mutations in a Patient with Von Willebrand Disease and Symptomatic Bleeding Disorder
Comprehensive Bleeding Disorder Panel
Platelets in Inflammation and Atherogenesis
Hematology Genetics Requisition Form
Resistance to Activated Protein C Due To
Identification of Mutations in SLC4A1, GP1BA and HFE in a Family with Venous Thrombosis of Unknown Cause by Next‑Generation Sequencing
The Role of Gpvi and Clec-2 in Platelet Activation by Miscellaneous Ligands
2504 Platelet Aggregation: Involvement of Thrombin and Fibrin(Ogen)
What Are Rare Clotting Factor Deficiencies?
Information for Patients with Heterozygous Factor V Leiden Mutation